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Abstract
Animals use TGF-b superfamily signal transduction pathways during development and tissue maintenance. The superfamily
has traditionally been divided into TGF-b/Activin and BMP branches based on relationships between ligands, receptors, and
R-Smads. Several previous reports have shown that, in cell culture systems, ‘‘BMP-specific’’ Smads can be phosphorylated in
response to TGF-b/Activin pathway activation. Using Drosophila cell culture as well as in vivo assays, we find that Baboon,
the Drosophila TGF-b/Activin-specific Type I receptor, can phosphorylate Mad, the BMP-specific R-Smad, in addition to its
normal substrate, dSmad2. The Baboon-Mad activation appears direct because it occurs in the absence of canonical BMP
Type I receptors. Wing phenotypes generated by Baboon gain-of-function require Mad, and are partially suppressed by
over-expression of dSmad2. In the larval wing disc, activated Baboon cell-autonomously causes C-terminal Mad
phosphorylation, but only when endogenous dSmad2 protein is depleted. The Baboon-Mad relationship is thus controlled
by dSmad2 levels. Elevated P-Mad is seen in several tissues of dSmad2 protein-null mutant larvae, and these levels are
normalized in dSmad2; baboon double mutants, indicating that the cross-talk reaction and Smad competition occur with
endogenous levels of signaling components in vivo. In addition, we find that high levels of Activin signaling cause
substantial turnover in dSmad2 protein, providing a potential cross-pathway signal-switching mechanism. We propose that
the dual activity of TGF-b/Activin receptors is an ancient feature, and we discuss several ways this activity can modulate
TGF-b signaling output.
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Introduction
TGF-b superfamily signaling controls a multitude of metazoan
cellular behaviors. Much of the signaling activity can be explained
by the canonical Smad pathway, wherein extracellular ligands
direct formation of active receptor complexes that phosphorylate
and activate R-Smad transcription factors [1]. Multiple levels of
regulation are known, ranging from extracellular ligand processing
to diverse post-translational modification of Smad proteins [2–3].
In addition, a number of Smad-independent signaling pathways
have also been demonstrated for various receptors and in different
cell types [4].
Two functional subfamilies in TGF-b signaling are generally
recognized based on genetic phenotypes and molecular studies: the
TGF-b/Activin branch and the BMP branch. Phylogenetic
analysis indicates that the TGF-b and BMP branches are present
in all metazoans [5], suggesting that a robust TGF-b signaling
network is an ancient feature of multicellular animals. The key
difference between the two branches is that they activate different
classes of R-Smads and thus induce different transcriptional
responses in target cells. The TGF-b/Activin ligands work through
Smad2/3 (dSmad2 in Drosophila) and BMP ligands work through
Smad1/5/8 (Mad in Drosophila). These selective outputs are
orchestrated by the Type I receptors, which bind to specific
extracellular ligands and phosphorylate specific subsets of R-
Smads.
Although genetic and molecular biology studies have consis-
tently indicated that TGF-b/Activin and BMP signals use different
R-Smads, there have been several reports of activation of BMP R-
Smads by TGF-b ligands. This cross-talk activity was observed in
several types of mammalian cells, but conflicting mechanisms were
put forth on how this is achieved. Goumans et al. [6] described
phosphorylation of BMP R-Smads upon TGF-b ligand exposure
in human endothelial cells, and they concluded that TGF-b and
BMP Type I receptors are both required for the reaction. Another
report suggested that TGF-b phosphorylation of BMP R-Smads in
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e36548human epithelial cells is accomplished by a BMP receptor [7]. In
that model, the receptor signaling complex again includes two
Type I receptors from different signaling branches: a TGF-b/
Activin receptor that both acts as a scaffold for the ligand and
phosphorylates TGF-b/Activin R-Smads, and a BMP receptor
that phosphorylates BMP R-Smads. However, two other studies
demonstrated that a human TGF-b/Activin receptor can
phosphorylate BMP R-Smads directly, eliminating any role for a
BMP receptor in some cell types [8–9]. Activin-to-BMP cross-talk
in Drosophila cell culture has also been reported [10], but the
receptor directly responsible for the Activin-stimulated phosphor-
ylation of Mad, the mechanisms by which this phosphorylation are
regulated, and whether such cross-pathway signaling occurs in vivo
at endogenous levels of the various signaling components are not
known.
In this report, we further explore these issues using both cell
culture and in vivo methods. We conclude that phosphorylation of
the Drosophila BMP R-Smad, Mad, by Baboon, encoded by the
only Type I TGF-b/Activin family receptor, is direct and is an
evolutionarily conserved signaling event. Furthermore, we find
that competition between R-Smads has a profound influence on
Baboon-to-Mad phosphorylation activity and that R-Smad
pathway switching can be promoted by loss of dSmad2.
Results
Activation of Baboon by mutation or by ligand
stimulation leads to phosphorylation of both Mad and
dSmad2
In order to define the molecular nature of cross-talk, we
employed a cell-based signaling assay that we have used to study
other aspects of TGF-b signaling [11]. Expression of a
constitutively active form of Baboon (Babo*) in Drosophila S2 cells
resulted in phosphorylation of both the Activin and BMP R-
Smads, dSmad2 and Mad (Figure 1A). To ensure that this
phosphorylation of Mad is a property of the Baboon receptor itself
and is not due to an artifact of the activating mutation in Babo*,
we exposed S2 cells to the Activin-like ligand Dawdle (Daw), which
signals through Baboon [12]. These cells, which express only
endogenous Baboon, also responded to Daw by robustly
phosphorylating both dSmad2 and Mad (Figure 1A). These results
demonstrate that an Activin ligand can stimulate the BMP
pathway in Drosophila S2 cells.
Mad phosphorylation by Baboon is independent of BMP
Type I receptors
As described above, a key mechanistic question is whether
Baboon can directly phosphorylate Mad or if the traditional BMP
receptors are involved. We addressed this point by conducting the
signaling assay in cells lacking specific TGF-b-family receptors due
to experimental RNA interference (RNAi). Similar to data shown
in Figure 1A, control cells whose receptors were not targeted by
RNAi accumulated phosphorylated Mad in response to the BMP-
type ligand Decapentaplegic (Dpp) or the Activin-type ligand Daw
(Figure 1B). Reducing expression of Punt, the only Type II
receptor expressed in S2 cells, by RNAi eliminated the response to
both ligands (Figure 1B). Cells lacking Baboon due to RNAi
depletion still phosphorylated Mad in response to Dpp, but not in
response to Daw (Figure 1B). In contrast, cells with both BMP
Type I receptors Saxophone and Thickveins knocked down by
RNAi still phosphorylated Mad upon exposure to Daw, even
though they had no response to Dpp (Figure 1B). The abolishment
of one or both ligand responses in each condition demonstrates the
effectiveness of the various RNAi treatments. Additionally, the
Saxophone and Thickveins RNAi treatments were validated for their
ability to essentially eliminate expression of these proteins (see
Figure S1). These results indicate that 1) BMP Type I receptors are
neither necessary nor sufficient for Activin-induced phosphoryla-
tion of Mad in S2 cells, and 2) Baboon is the lone Drosophila Type I
receptor that is necessary and sufficient for Activin-to-BMP cross-
talk.
Cross-talk is a conserved property of TGF-b receptor
intracellular domains
Recent work has uncovered functional differences among
isoforms of the sole Activin receptor in Drosophila. The three
isoforms have divergent extracellular domains and identical kinase
domains, and only one isoform, Baboc, is activated by the Daw
ligand in S2 cells [12]. We wondered if the isoform differences
might influence the ability to phosphorylate Mad, perhaps by
directing different receptor complexes to form via extracellular
interactions. We tested whether the other isoforms of Baboon,
Baboa and Babob, were also able to stimulate cross-talk. When
over-expressed in S2 cells, both of these isoforms displayed activity
in the absence of exogenous ligand, and induced phosphorylation
of both dSmad2 and Mad (Figure 2A). This result is consistent
with studies suggesting that the kinase domain’s L45 loop–a
portion of the protein identical in Baboon isoforms–is primarily
responsible for substrate recognition [13]. Extracellular differences
among isoforms do not control cross-talk activity, supporting the
Figure 1. Stimulation of the Baboon receptor leads to
phosphorylation of both R-Smads independently of BMP Type
I receptors. S2 cells were transiently transfected with FLAG-tagged
Smad expression constructs and analyzed by Western blot for C-
terminal phosphorylation (P-dSmad2 and P-Mad). The FLAG-Mad band
is shown as a loading control (FLAG-dSmad2 is not a useful loading
control because of signaling-induced degradation as described later in
the text). For all Western blot figures, a thin horizontal line indicates
different infrared channels from the same blot. Co-expression of a
constitutively active form of Baboon (Babo*) led to phosphorylation of
dSmad2 and Mad (A, left blot). Exposure of cells expressing
endogenous Baboon to the Dawdle ligand (Daw) had the same effect
(A, right blot). RNAi treatment was used to determine receptor
requirement for ligand activity (B). Controls confirmed that Dpp ligand
treatment caused Mad phosphorylation independently of Baboon (B,
left half). Dpp activity required the Punt Type II receptor and the Tkv
and Sax BMP Type I receptors (B, right half). In contrast, Daw signaling
to Mad required Baboon and Punt, but not Tkv and Sax.
doi:10.1371/journal.pone.0036548.g001
Activin/BMP Cross-Pathway Signaling
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domain of Baboon.
Many reports have demonstrated that members of the same
TGF-b-family pathway are interchangeable across species. For
example, expression of a human BMP ligand can rescue mutation
of a Drosophila BMP ligand in vivo [14]. We were curious if trans-
species cross-talk was also possible. We tested whether activated
TGF-b/Activin Type I receptors from mammals could phosphor-
ylate the Drosophila BMP R-Smad. When transfected into S2 cells,
the constitutively active forms of mammalian Activin receptors
Alk4 and Alk7, like Babo*, could induce phosphorylation of both
dSmad2 and Mad (Figure 2B and not shown). This interaction
highlights the strong evolutionary conservation of the described
cross-talk phenomenon.
An in vivo Baboon gain-of-function phenotype is
primarily mediated through Mad and not dSmad2
Given the demonstrated ability of Baboon to phosphorylate
Mad and dSmad2 in cell culture, we looked for evidence that
Baboon can signal through Mad in vivo. Previous studies have
shown that moderate expression of Babo* in developing wings can
generate enlarged but normally patterned wings [15]. We found
that Babo* expression in the imaginal wing using the vg-GAL4
driver led to visible adult wing defects (Figure 3B, C). To
determine whether activation of Mad or dSmad2 caused the
phenotype, we used RNAi to remove one R-Smad at a time in
wings expressing Babo*. vg-GAL4 driving mad RNAi alone
produced a small, flat wing with missing veins (Figure 3E),
whereas the effect of dSmad2 RNAi knockdown alone was a
moderately blistered wing (Figure 3F). When mad was removed in
the presence of Babo*, the blistered and crumpled Babo* wing
phenotype was suppressed (Figure 3H), and the resulting wings
resembled those expressing mad RNAi alone. In contrast, removal
of dSmad2 by RNAi did not suppress the wrinkling phenotype
induced by Babo*; in fact, the phenotype became more severe.
The dSmad2 RNAi, Babo* wings were more wrinkled and
shrunken than wings where either construct was expressed alone
(Figure 3I), suggesting that in the absence of dSmad2 more Mad is
phosphorylated, perhaps because of less competition between
dSmad2 and Mad for Baboon binding.
In support of this concept, we found that over-expression of
dSmad2 suppressed the blistered wing phenotype of Babo*
(Figure 3G), whereas dSmad2 over-expression alone did not affect
wing size or vein formation (Figure 3D). This result rules out a
general influence of dSmad2 on Mad activity and instead indicates
that dSmad2 dosage specifically modifies the substrate choice of
Baboon.
dSmad2 directly influences Baboon’s phosphorylation of
Mad
Competition between dSmad2 and Mad for interaction with
Baboon is a straightforward model. We carried out additional tests
in cell culture and in vivo to confirm that the dSmad2 protein
concentration affects Mad activation. As one test of the model of
competitive binding between R-Smads, we manipulated levels of
dSmad2, Baboon’s hypothetically preferred substrate, in the S2
cell signaling assay.
As noted above, Babo* expression or prolonged Daw stimula-
tion led to phosphorylation of Mad in S2 cells. Steady-state levels
of P-Mad or P-dSmad2 after prolonged Babo* expression were
similar whether Mad or dSmad2 were expressed individually or
together (data not shown). As a more sensitive assay, we performed
time-course experiments using Daw ligand to observe the initial
kinetics of substrate phosphorylation. When Flag-dSmad2 was
overexpressed, P-dSmad2 accumulated steadily over a several
hour exposure to Daw (Figure 4A, right lanes). Endogenous P-
dSmad2 was also detected upon Daw treatment, but the
accumulation was not linear. The rate of P-Mad accumulation
varied with the expression level of dSmad2. When Flag-Mad was
the only over-expressed substrate, P-Mad was detected after
1 hour and continued to rise during 3 hours of ligand exposure
(Figure 4A, middle lanes). This accumulation was modestly
enhanced when endogenous dSmad2 was eliminated by RNAi
(Figure 4A, left lanes). In the other direction, over-expression of
Flag-dSmad2 suppressed the accumulation of P-Mad such that it
was not detectable above background after 3 hours of Daw
exposure (Figure 4A, right lanes). Quantified P-Mad signals are
plotted in Figure 4A. This result implicates dSmad2 protein in
controlling the rate of Mad phosphorylation by Baboon in S2 cells.
We considered several possibilities for how this might occur.
First, in vertebrate systems, the Activin/TGF-b R-Smads are
assisted in their presentation to a receptor by SARA (Smad
Anchor for Receptor Activation) [16], an endosome-associated
protein that potentially could provide a competitive edge to
dSmad2 over Mad for phosphorylation by Baboon. However,
RNAi knockdown of SARA in S2 cells had no affect on the
dSmad2/Mad phosphorylation ratio (see Figure S2A), suggesting
that differential presentation of dSmad2 to Baboon by SARA is
not a likely mechanism for substrate choice. Another possibility is
that molecular motors contribute to substrate preference by
discriminately presenting one Smad to the receptor. In Xenopus,
one report suggests that efficient Smad2 phosphorylation requires
kinesin motors, presumably to help traffic Smad2 to the receptor
[17]. We treated cells with colcemid to depolymerize microtubules
and block potential transport mechanisms, but we did not observe
a change in the relative phosphorylation of dSmad2 and Mad (see
Figure S2B).
Since we found no evidence for differential presentation to
receptors, we decided to test more directly the direct-binding/
competition model by altering the receptor interaction interface of
dSmad2 to make it more similar to Mad. We reasoned that if there
was direct competition between these two R-Smads for binding to
Baboon, then Baboon would phosphorylate both substrates at
similar rates if they had similar interaction interfaces. Previous
Figure 2. All isoforms of Baboon and mammalian Activin
receptors can initiate cross-talk. (A) Overexpression of wildtype
Baboa or Babob in S2 cells led to phosphorylation of dSmad2 and Mad.
In this experiment there was a detectable background level of P-
dSmad2 well below the Babo-induced levels. Arrowhead indicates that
the displayed image contains two portions of one blot. (B) Constitu-
tively active versions of mammalian Activin receptors Alk4 and Alk7
(Alk4* and Alk7*), like Babo*, induce phosphorylation of Drosophila Mad
in S2 cells.
doi:10.1371/journal.pone.0036548.g002
Activin/BMP Cross-Pathway Signaling
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Smad1/5/8 identified two residues in the L3 loop of the MH2
domain as key for targeting different Smads to the L45 loop of
either TGF-b/Activin or BMP receptors [18]. We changed the
R446 and T449 residues of dSmad2 to H and D, respectively, to
give dSmad2 a Mad-like L3 loop. We also made a variant of
dSmad2 that harbors the E300K substitution in the MH2 domain
found in the dSmad2
MB388 allele [19].
We compared the relative phosphorylation levels of wildtype
(WT) and mutant forms of dSmad2 versus Mad in response to
Baboon. In the experiment shown in Figure 4B, the steady-state P-
dSmad2(WT) signal was greater than the P-Mad signal, and the
E300K and HD variants had reduced P-dSmad2. Importantly, the
P-Mad signal increased as the P-dSmad2 signal decreased, which
is consistent with the substrate competition model. This behavior
was confirmed in a Daw time-course experiment for dSmad2(WT)
and dSmad2(HD). During the first hours of signaling, phosphor-
ylation of the HD variant was dramatically reduced compared to
WT. P-Mad accumulation, modest over this time range when
forced to compete with dSmad2(WT), was enhanced when pitted
against the less effective dSmad2(HD) protein (Figure 4B).
dSmad2 restricts Baboon-Mad cross-talk activity in vivo
These signaling assays in S2 cells demonstrate that the Baboon
kinase can use Mad as a substrate and that dSmad2 levels
modulate the phosphorylation of Mad by Baboon. We next sought
to determine if these two phenomena occur in vivo. We chose the
wing disc as a platform to manipulate Baboon because the normal
P-Mad pattern is well characterized and, as described below,
seems to be independent of canonical dSmad2-Baboon signaling.
Wing discs from third-instar larvae have a well-defined pattern of
P-Mad that critically depends on the Dpp ligand and the BMP
Type I and Type II receptors Tkv and Punt, respectively. baboon is
expressed in the wing disc, but baboon mutants display a normal P-
Mad pattern ([15] and Figure 4E). Similarly, dSmad2 is expressed
in discs, but removal of dSmad2 in the wing pouch by RNAi did
not significantly alter the P-Mad pattern (Figure 4D, compare to
4C). The lack of an aberrant P-Mad pattern after reduction of
either Baboon or dSmad2 is consistent with a lack of appreciable
cross-talk activity in the larval wing disc at this developmental time
under endogenous conditions.
Against this backdrop, we manipulated Baboon signaling in
wing discs and used P-Mad staining patterns as an indicator of
activity. When expressed in the L3 wing disc blade using a vg-
GAL4 driver, constitutively active Babo* altered the P-Mad
pattern. Curiously, the P-Mad signal was reduced in the wing
blade, disrupting the normal gradient pattern (Figure 4F). This
resembled a loss-of-function condition for Thickveins (compare to
Figure 4I) that is likely caused by titration of Punt away from BMP
signaling complexes. Indeed, when Punt was co-expressed with
Babo*, P-Mad was detected throughout the vg-GAL4 pouch
region (Figure 4H). The Punt expression line used for this
experiment did not induce ectopic P-Mad in the wing pouch by
itself (not shown). It is likely that Babo*-Punt complexes are active
towards dSmad2, but we could not directly verify this because no
P-dSmad2 immunohistochemistry (IHC) detection assay is avail-
able. However, we were able to show that dSmad2 impacts the
output of Babo* by simultaneously expressing Babo* and knocking
down endogenous dSmad2. This combination produced strong
ectopic P-Mad throughout the vg-Gal4 expression domain
(Figure 4G). Once again, we interpret these data as reflecting a
competition between dSmad2 and Mad proteins for binding to
and activation by Baboon. Reinforcing the result seen in S2 cells,
this in vivo scenario implicates dSmad2 as the preferred substrate
for Baboon since endogenous dSmad2 protein can prevent over-
expressed Baboon from phosphorylating Mad.
We also tested if Babo* phosphorylation of Mad can occur
independently of the relevant BMP Type I receptor in the wing
disc. Simultaneous Babo* expression and dSmad2 RNAi led to
ectopic P-Mad even with effective knockdown of tkv (Figure 4K).
Figure 3. Excessive Baboon signaling perturbs wing development in a Mad-dependent manner. vestigial-GAL4 (vg) was used to express
combinations of Baboon, dSmad2, and RNAi for mad and dSmad2. Normal wing development (A; one copy of vg-GAL4) was disrupted by Babo*
expression (B, C; Babo*mod and Babo*strong are UAS insertions with varying activity as characterized in other assays). The Babo* phenotype was
abrogated by simultaneous mad RNAi (H) and resembled mad RNAi alone (E). In contrast, the crumpling defect of Babo* wings was enhanced in
conjunction with dSmad2 RNAi (I) and was more severe than dSmad2 RNAi alone (F). Overexpression of FLAG-dSmad2 did not affect wing formation
(D), but partially rescued the Babo* overexpression phenotype, producing normal sized flat wings with residual peripheral vein defects (G). For each
genotype, a representative wing is shown out of 4–7 wings photographed. Within a genotype there was only slight variation in appearance, except
that 3/6 dSmad2 RNAi wings had vein defects and a blister (shown) and 3/6 had vein defects without a blister (not shown).
doi:10.1371/journal.pone.0036548.g003
Activin/BMP Cross-Pathway Signaling
PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e36548Figure 4. Baboon phosphorylation of Mad is inhibited by dSmad2. (A) Phospho-Smad accumulation upon exposure to Daw ligand. S2 cells
transfected with Flag-Mad were treated with dsRNA for dSmad2 or GFP, and transfected with Flag-dSmad2 as indicated. Phospho-Smad and Flag
signals were assayed on samples before Daw exposure and after 1 and 3 hours of incubation. Note that there is a gel artifact affecting the appearance
of the Flag bands in several lanes. Quantified P-Mad band intensities are plotted to illustrate that accumulation of P-Mad depends on the level of
dSmad2. The experiment was repeated with several batches of reporter cells, and the relative signals for the 3 hour time point were always observed
in the same order. The 1 hour time points were near background detection and are less reliable due to noise. (B) Mutated dSmad2 proteins with
varying phosphorylation efficiency modulate the rate of P-Mad accumulation. Babo* stimulation revealed the steady-state levels of P-dSmad2 and P-
Mad. Daw exposure for 1 or 4 hours showed the difference in response to short-term signaling between the WT and HD forms of dSmad2. In both
conditions, P-Mad levels were inversely correlated to P-dSmad2 levels. (C–K) Wing imaginal discs from third instar larvae were stained to detect P-Mad
Activin/BMP Cross-Pathway Signaling
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direct Baboon to Mad cross-talk in vivo.
Dosage effects at endogenous levels: P-Mad levels
increase in some tissues of dSmad2 protein-null animals
Given the observation that the presence of dSmad2 in the wing
disc profoundly alters the activity of exogenous Babo*, we asked if
a similar effect is observed with endogenous levels of TGF-b
signaling components. To do this, we required a protein-null
condition to preclude competition between Mad and dSmad2
binding to Baboon. The only available dSmad2 mutant allele,
dSmad2
MB388, harbors a mis-sense mutation near the beginning of
the MH2 domain. This mutation does not prevent interaction with
Baboon, as the corresponding E300K protein was robustly
phosphorylated in S2 cells by Babo* (Figure 4B). To generate a
protein null allele, we excised P(G0348), a white-marked P element
located approximately 400 nt downstream of the dSmad2 tran-
scriptional start, and screened for white
2 lethal progeny (see
Materials and Methods). Among several candidates, one allele,
dSmad2
F4, was a deletion of the entire coding sequence (Figure 5A).
We next surveyed P-Mad levels by IHC in various tissues derived
from dSmad2 mutant larvae. We observed that many, but not all,
tissues displayed greater P-Mad staining in the dSmad2 mutant
compared to control animals reared under the same conditions.
For example, nuclear P-Mad in the fat body was weakly detected
in control animals, but markedly elevated in dSmad2
F4 mutants
(Figure 5B1 vs FB2). A similar increase was seen at various
positions along the gut tract: P-Mad staining was elevated in the
gastric caeca, the midgut/hindgut junction, and Malpighian
tubules compared to equivalently stained control larvae (examples
in Figure 5C and 5D, and summary in Figure S3).
We next tested the influence of the Baboon receptor on P-Mad
levels in the fat body and gut. In contrast to dSmad2 mutants,
baboon mutant animals had normal P-Mad staining (Figure 5B3,
5C4 and 5D4). The low level of nuclear P-Mad seen in wildtype
and baboon-mutant gut tissue is presumably due to canonical BMP-
family signaling through Thickveins and Saxophone receptors. We
next performed an epistasis test in which we assayed P-Mad levels
in a dSmad2; babo double mutant. We reasoned that if the ectopic
P-Mad in a dSmad2 protein-null mutant is due to enhanced
phosphorylation of Mad by Baboon, then it should be suppressed
in the double mutant. We observed this result in all tissues
examined (Figure 5B4, 5C5 and 5D5, and Figure S3). Thus,
Baboon function is required to produce the elevated P-Mad levels
observed in dSmad2 deficient tissues. To explain this phenomenon
we conclude simply that Baboon activity is directed towards Mad
when dSmad2 is not present in vivo.
Baboon activation causes bulk degradation of dSmad2
During our experiments in S2 cells, we observed that over-
expression of activated Baboon significantly lowered the level of
co-over-expressed dSmad2 protein. In these experiments S2 cells
were transfected with actin promoter expression constructs and
were assayed several days later. Thus the dSmad2 protein level
detected by Western blot represents the steady-state level, which
reflects the production and degradation rates. Protein production
rates should be constant in this system, so changes in the steady-
state level of dSmad2 can be interpreted as changes in the
degradation rate. By this measure, the degradation rate of dSmad2
increased about 5- to10-fold when Babo* was present (Figure 6A).
We next tested this behavior in several in vivo situations to
determine the generality of the bulk degradation of dSmad2 upon
Baboon activation. Western blot detection of dSmad2 from
embryo extracts showed that co-expression of Babo* lowered the
dSmad2 level about 5-fold, compared to dSmad2 expression alone
(Figure 6B). A similar reduction of exogenously expressed dSmad2
was seen in the wing blade upon expression of Babo* (compare
Figure 6D to 6C). These results confirm that Baboon stimulation
lowers dSmad2 stability in vivo. Below we consider how such
degradation could alter the output of Baboon signaling in the
context of cross-talk.
Discussion
Comparison with cross-pathway signaling in other
systems
In this report we present experimental results showing that the
Baboon receptor can directly phosphorylate Mad in cell culture
and in vivo, and that this cross-talk activity is tightly controlled by
the availability of dSmad2. These findings extend the initial report
describing canonical signaling between Baboon and dSmad2
where dSmad2, but not Mad, was shown to be a substrate of
Baboon in mammalian cells [15]. There are several possible
reasons why Baboon-Mad activity is observed in Drosophila cells
but was missed in the initial report. First, it is possible that Mad
binding to Baboon may be too weak or transient to be detected by
immunoprecipitation. Alternatively, endogenous Smad2/3 may
have blocked the interaction in heterologous cell systems, or
species-specific co-factors may facilitate Mad-Baboon binding.
The strong functional conservation of TGF-b superfamily
proteins prompts a comparison of our results in Drosophila with
studies describing cross-pathway signaling in mammalian systems.
The limited number of pathway members and the efficacy of
RNAi in Drosophila enabled us to distinguish between competing
models presented for mammalian epithelial cells. With regard to
the key mechanistic question of whether TGF-b Type I receptors
can directly phosphorylate the BMP R-Smads, our observation of
Mad phosphorylation in the absence of BMP Type I receptors
(Figure 1) is inconsistent with the model of heteromeric TGF-b/
BMP Type I receptor complexes proposed by Daly et al. [7], but is
consistent with the model of direct phosphorylation of BMP R-
Smads by TGF-b/Activin receptors proposed by Liu et al. [8]. It is
possible that both types of mechanisms exist, but are differentially
utilized depending on the ligands and receptors present in the
and imaged by confocal microscopy. For each condition at least three discs were imaged, and a representative Maximal Intensity Projection
encompassing the wing blade is shown (6 sections @ 3 micron interval for C,D,F–H; all sections @ 3 micron interval for E; 5 sections @ 2 micron
interval for I–K). Anterior is to the left and the scale bar shown in panel C applies to C–K. The normal P-Mad staining pattern is shown for vg-GAL4
alone (C; scale bar=100 microns). Expression of a UAS-dSmad2 RNAi construct did not alter the P-Mad pattern or the shape of the wing disc (D). Wing
discs from babo
fd4/fd4 homozygotes showed nearly normal pMad gradient (E). Expression of Babo* altered P-Mad staining, obliterating the normal
gradient in the pouch (F). Note the normal P-Mad staining outside of the pouch where vg-Gal4 is not expressed. Babo* and dSmad2 RNAi together
generated ectopic P-Mad in the entire wing pouch (G). Providing Babo* with additional Punt also produced ectopic P-Mad (H). tkv RNAi prevented P-
Mad accumulation in the middle of the wing pouch (I), and addition of Babo* did not counteract this P-Mad pattern (J). Additional knockdown of
dSmad2 led to ectopic P-Mad (K), which paralleled the results without tkv RNAi. Data in panels C, D, F, and G were from the same experiment and
were stained in parallel. Panel H is from a different experiment, but the pouch signals can be compared to the others because the endogenous P-Mad
along the posterior margin has similar staining. Samples in panels I–K were stained and processed in parallel.
doi:10.1371/journal.pone.0036548.g004
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PLoS ONE | www.plosone.org 6 May 2012 | Volume 7 | Issue 5 | e36548Figure 5. P-Mad elevation in dSmad2 null mutant tissues depends on baboon. The schematic depicts the location of the l(X)G0348 P element
insertion in relation to the dSmad2 locus (A). The F4 excision product removed the entire coding region of dSmad2 and portions of the P-element. The
genomic breakpoints are indicated above the dSmad2 mRNA; they were determined by sequencing PCR products, indicated by dotted lines. (B–D) P-
Mad was detected by IHC of fixed larval tissues from several genotypes. For each image, a merged DAPI (blue) and P-Mad (red) panel is displayed
above the isolated P-Mad channel. (B) Single confocal sections of P-Mad staining in the fat body. Under the staining conditions employed,
endogenous nuclear P-Mad in a control fat body was barely detected (B1), but was increased in a dSmad2 null mutant animal (B2). Baboon single
mutants and dSmad2; baboon double mutants had normal P-Mad staining (B3,4). (C, D) P-Mad staining at two representative positions along the
digestive tract. Images are Maximal Intensity Projections of 3 micron interval confocal sections through the entire sample. The P-Mad primary
antibody was omitted from ‘‘No Ab Control’’ samples to convey any background staining and auto-fluorescence in the red channel. (C) In the gastric
caeca near the proventriculus, dSmad2 mutants showed elevated P-Mad (C3) compared to wildtype control males (C2). baboon single mutants and
dSmad2; baboon double mutants showed wildtype levels (C4 and C5). Distal Malpighian tubule staining (lumpy tubes marked with asterisks) showed
the same pattern, with the dSmad2 mutant displaying the strongest P-Mad staining (D3 compared to D2, D4 and D5).
doi:10.1371/journal.pone.0036548.g005
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direct action of Baboon on Mad does not preclude the possibility
that mixed receptors form active signaling complexes in some
situations. Mixed receptor complexes have been detected in
Drosophila cell culture under over-expression conditions, but their
functionality is unknown [20]. A similar point can be made
regarding mixed Smad oligomers detected in mammalian
epithelial cells by Daly et al. [7]. In our adult wing assay, we
found that the Babo* phenotype depended primarily on Mad and
that dSmad2 was not required. If the wing development defect was
caused by the activity of a complex containing both P-Mad and P-
dSmad2, then removal of either one should have blocked the
Babo* phenotype. Again, this observation does not argue against
the formation or activity of mixed R-Smads complexes in some
contexts, but shows that productive signaling by cross-pathway
phosphorylation can take place independently of such complexes.
One key observation in this report concerning the mechanism of
cross-pathway signal regulation is that the degree to which it
occurs, both in cell culture and in vivo, appears to be regulated by
competition between the R-Smads, likely for receptor binding.
Further work is required to determine how general this
mechanism might be. Epithelial cell culture models showed that
cross-talk is important for the TGF-b-induced migratory switch
[8]. Our results in the larval wing disc and gut represent the first
examples of cross-talk in vivo, and we expect that additional
examples will be found in various animals and tissues. With regard
to developmental studies, other systems should be evaluated to see
if loss-of-function mutations of Smad2/3 orthologs lead to
increased signaling through BMP R-Smads. Additionally, several
human diseases have been attributed to mutations in TGF-b
components [21]. A cautionary implication of our work is that
mutations in the TGF-b branch may have unanticipated loss- or
gain-of-function influences on the BMP branch.
Curiously, TGF-b/Activin Type I receptors appear to have
gained or retained cross-phosphorylation activity throughout
evolution, but BMP Type I receptors do not appear to have
reciprocal activity. We have never seen phosphorylation of
dSmad2 by activated Drosophila Type I BMP receptors (Figure 6A
and data not shown), or in response to various ligands. Likewise,
no phosphorylation of Smad2/3 by BMP receptors has been
reported in vertebrate cells. Why is there this distinction? The
growing number of complete genome sequences has allowed
phylogenetic reconstruction of the evolution of TGF-b signaling
[5]. Apparently all metazoans, even the simple placazoan [22],
have a complex TGF-b network containing both TGF-b/Activin
and BMP subfamilies. It is tempting to speculate that a single
receptor with dual Smad targets could have played a transitional
role in the expansion of the signaling network. The all-or-none
nature of the TGF-b-superfamily network (both BMPs and TGF-
b/Activins present, or none) in extant organisms, however, does
not provide support for this idea. What it does support is the
possibility that relationships between core pathway proteins
stabilized hundreds of millions of years ago. If the dual-kinase
activity of Baboon orthologs has been available to all metazoans
during the radiation of animal forms, we would expect this activity
to be deployed by different animals and different cell types in
diverse ways. We are currently investigating several phenotypes
that differ between baboon and dSmad2 mutants to determine which
depend on Babo-Mad cross-talk and which might depend on other
forms of Smad-independent signaling [23].
Smad2 degradation as a signaling switch
The different responses of adult wings and larval imaginal tissue
upon Baboon activation (Figures 3 and 4) illustrate that TGF-b
pathway wiring and output can vary with developmental context.
Given the relationship between Babo and dSmad2, the cross-talk
activity can be viewed two ways. From one perspective, the
response to loss of dSmad2 depends on the level of Baboon
signaling: only cells with Baboon activity can produce P-Mad by
cross-talk. From the other perspective, the response of wildtype
Figure 6. Hyperactive Baboon signaling leads to dSmad2
destabilization. The steady-state level of transfected dSmad2 in S2
cells was significantly reduced when Babo* was co-expressed (A).
Quantified band intensities are displayed as a percentage of the control
for each channel. Note that the P-dSmad2 level was greatly increased
but the total dSmad2 level was reduced in the presence of Babo*,
causing a greater than 1000-fold increase in the ratio of P-dSmad2 to
total Flag-dSmad2. This effect was specific to Babo*, as inclusion of
activated Saxophone (Sax*) neither stimulated P-dSmad2 nor signifi-
cantly decreased the FLAG-dSmad2 signal (A, right lane). FLAG-dSmad2
was expressed in embryos using the da-GAL4 driver, either alone or
with Babo* (B). Total exogenous dSmad2 and P-dSmad2 was detected
by Western blot and the amount of FLAG-dSmad2 was normalized to
endogenous alpha-tubulin. (C, D) vg-GAL4 was used to express Flag-
dSmad2 alone (C) or with Babo* (D) in the wing disc. FLAG antibody IHC
was used to gauge dSmad2 levels (red), and DAPI (blue) and aPKC IHC
(green) are shown as counter-stains. Each image is a single confocal
plane through the wing blade, and represents at least three discs
stained per genotype.
doi:10.1371/journal.pone.0036548.g006
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cross-talk will only occur in the absence of dSmad2.
Given the dominant control that dSmad2 exerts on the ability of
Baboon to phosphorylate Mad, the simplest model is that output
of TGF-b ligand stimulus in a given cell depends on the expression
level of dSmad2 (Figure 7A). Although dSmad2 is widely
expressed, as are Smad2/3 proteins in other animals, different
subsets of cells might express different ratios of R-Smads that could
influence the signaling output.
Our observation that Baboon activity can lower the overall level
of dSmad2 protein offers an additional regulatory possibility,
where the TGF-b/Activin signal itself can influence its response.
In the substrate-switch model, a cell exposed to a prolonged
Activin signal would eventually degrade enough of its dSmad2
pool to allow Baboon signaling through Mad (Figure 7B). It is not
known which tissues, if any, require Baboon-to-Mad signaling in
normal developmental contexts. We have observed that in some
cases, dSmad2 over-expression leads to mad loss-of-function
phenotypes, which could represent disruption of a sensor
incorporating dSmad2 concentration as an input and Mad activity
as an output (unpublished observations). Proteosomal degradation
of activated Smad proteins is a well documented mechanism of
signal attenuation [24], but the current observation of bulk
degradation adds a new dimension because it can redirect receptor
signaling. The mechanism of signal-dependent bulk dSmad2
degradation is unknown, and preliminary experiments do not
Figure 7. Models of signaling outputs generated by dual kinase activity of the Baboon receptor. Given the potential of Baboon to
phosphorylate and activate dSmad2 and Mad, we present several configurations of Baboon, dSmad2 and Mad interaction that would generate
different signaling outputs. In each schematic, only the most relevant pathway components are drawn. The first model represents a logic gate, where
the ability of Baboon to phosphorylate Mad is strictly controlled by the expression of dSmad2 in that cell (A). Another model incorporates the
observed degradation of dSmad2 in response to Baboon signaling (B). The final model (C) incorporates feed-back or feed-forward of Mad activity
through dSmad2 regulation. If P-Mad positively regulated dSmad2 this would prevent the complete loss of dSmad2. Conversely, if P-Mad negatively
regulated dSmad2 expression, this would enforce the switch from Baboon signaling through dSmad2 towards Mad.
doi:10.1371/journal.pone.0036548.g007
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lished observations). Regardless of the molecular details, the
observed reduction of total dSmad2 available for receptor
competition is the key parameter in our competition model. Since
activated R-Smad proteins can also be dephosphorylated to rejoin
the pool of would-be substrates, the relative rates of recycling and
bulk degradation would be predicted to influence the substrate
switch to Mad.
What could be gained by the substrate switch? A general answer
is that multiple interactions permit diverse regulatory schemes. For
example, cross-talk would permit Mad signaling in a cell that is not
exposed to BMP ligands or is otherwise not competent to
transduce such signals. Other modes of signal integration are
intriguing, such as the conditional formation of mixed R-Smad
complexes observed by Daly et al. [7]. Another type of regulatory
link that could contribute to the evolutionary maintenance of an
integrated dSmad2-Babo-Mad triad is depicted in Figure 7C. If
dSmad2 transcription were a target for P-Mad, this would affect the
substrate switch. In once case, Baboon signaling to Mad would be
triggered by dSmad2 depletion and serve to up-regulate Smad2 to
return balance to the system. On the other hand, if dSmad2 were
down-regulated by P-Mad, this would stabilize the switch to the
Baboon-Mad interaction. Additional studies are required to
explore these intriguing possibilities.
Materials and Methods
Signaling assays in S2 cells
The S2 signaling assay has been described [12]. Briefly,
conditioned media was collected from cells that expressed a
construct encoding Dawdle. This media was mixed 1:1 with cells
that had been transfected with a combination of Smads [11] and
resuspended in their own media. Conditioned media from cells
that were mock transfected was used as a negative control;
recombinant Dpp (R&D Systems) was added to conditioned media
at a final concentration of 20 nM for BMP stimulation. Mutated
forms of dSmad2 (E300K and HD=R446H+T449D) were
generated by site-directed mutagenesis and the changes were
verified by sequencing. Constructs encoding different isoforms of
Baboon are described by Jensen et al. [12]. Expression vectors for
Babo* and Sax* are described by Gesualdi and Haerry [10].
Mammalian Alk4* and Alk7* [25,26] were cloned into the pAcPA
vector for S2 cell expression.
RNAi treatment of S2 cells was as described [12], except that
for Figure 4A dsRNA was added only once after transfection.
Primers used to make PCR products for T7 transcription
templates against tkv, sax, and punt are described by Shimmi and
O’Connor [27] and GFP dsRNA was used as a negative control
[28]. Additional primers for RNAi are as follows:
dSmad2 forward–TAATACGACTCACTATAGGGA-
GAGGGCAAGTGGTCAGAGAA;
dSmad2 reverse–TAATACGACTCACTATAGG-
GATGCCCACACTAAGCACACTC;
babo forward–TAATACGACTCACTATAGG-
GACCTGCGCTCCGGCTAATCTTCC;
babo reverse–TAATACGACTCACTATAGGGACG-
GATGATAGCCACAAACTCCC;
dSARA forward–TAATACGACTCACTATAGGGG-
TATCGTCCTCCGAATCGCTGAC;
dSARA reverse–TAATACGACTCACTATAGGG-
GATTTAGGGTTTGTGGTCGCTGGGG.
Cells for microtubule disruption tests were exposed to a final
concentration of 2 mg/mL colcemid in their own media for
2 hours prior to signaling assays. Control samples were treated
similarly, but without drug pre-treatment. After the signaling
assay, cells were pelleted, resuspended in 16 sample buffer, and
boiled. Samples were resolved on NuPAGE 4–12% Bis-Tris gels
(Invitrogen) and transferred to PVDF or nitrocellulose (Figure 4A
only) membrane after electrophoresis. Membranes were probed
with primary antibodies against C-terminally phosphorylated Mad
(1:1000, gift from E. Leof), phosphorylated dSmad2 (1:1000, Cell
Signaling #3108), the FLAG epitope (1:2000, Sigma (M2)), or
Saxophone (1:1000, Fabgennix). Membranes were exposed to
secondary antibodies (Rockland (IRDye)) and imaged on the
Odyssey Infrared Imaging system. To obtain fold change of
degradation rates of FLAG-dSmad2 under steady-state conditions,
we quantified the bands and calculated the ratio of unstimulated to
Babo*-stimulated FLAG-dSmad2. This simple formula applies if
production is constant and degradation is assumed to be a first
order reaction.
Fly lines
The vg-GAL4 driver (Bloomington stock #8229) was used to
drive expression of several UAS constructs in the developing wing,
and da-GAL4 (Bloomington stock #5460) was used to drive
expression in the embryo. UAS-Babo* lines have been reported
previously [15], as has the UAS-FLAG-dSmad2 overexpression
line [29]. dSmad2
MB388 and babo
fd4 are described in Zheng et al.
[19]. UAS-punt is described in Marque ´s et al. [30].
New RNAi lines were made using the pUAST-R57 vector
(National Institute of Genetics, Japan) and included gene-specific
sequences spanning bases 1264–1700 of the mad transcript
(U10328; insertion line 6C3), 1469–1928 of the dSmad2 transcript
(AF101386; insertion line 25A3 or 3B3), and 926–1461 of the tkv
transcript (NM_175975; recombinant line 38D2, 1A2). P-element-
mediated insertions were made and mapped using standard
techniques.
Larval IHC and tissue handling
Tissues from wandering third-instar larvae were fixed in 3.7%
formaldehyde in PBS for 25 minutes, washed in PBS-Triton
(0.1%), treated with primary antibody overnight at 4uC, exposed
to secondary antibodies (Alexa Fluor 488 or 568; 1:200) at room
temperature for two hours, and counterstained with DAPI. The P-
Mad antibody (gift from E. Leof) was affinity purified against a
peptide corresponding to the di-phosphorylated C-terminus of
Mad. M2 monoclonal antibody (Sigma) was used to detect FLAG-
tagged proteins. Anti-PKCf (rabbit polyclonal, Santa Cruz) was
used to visualize cell membranes for Figure 6. Confocal images
were collected using a Zeiss Axiovert microscope with a CARV
attachment, or with a Zeiss LSM710. The images in Figure 4C–H
and 6C,D were collected using a 206/0.75NA objective (CARV).
The images in Figure 5C,D were collected using a 106/0.45NA
objective (CARV). The images in Figure 4I–K and Figure 5B were
collected using a 206/0.80 NA objective (LSM). Where indicated
in Figure Legends, Maximum Intensity Projections were generated
using Axiovision (CARV images) or ImageJ (LSM images)
software.
Wings from adult females were dissected in ethanol and
mounted in 1:1 Canada balsam:wintergreen oil under a coverslip
for light microscopy using a 46/0.16NA objective. All flies for
wing and wing disc studies were reared on standard cornmeal
medium at 25uC. Larvae for whole-animal P-Mad IHC were
grown on yeast paste agar plates, and mutant animals were
identified by the absence of GFP balancers. Embryo extracts were
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reducing sample buffer, and the soluble fraction was used for
Western blot analysis.
Generation of a null dSmad2 mutant
A new dSmad2 allele was generated by imprecise excision of a P
element from stock l(X)G0348 (Flybase allele smox
G0348), which is
located in the dSmad2 59 UTR. P-element males carrying a
duplication (Tp1;2 sn+ 72d) to provide viability were outcrossed,
and male progeny lacking the visible eye color marker were
recovered and tested for lethality. Lethal chromosomes were
analyzed by PCR and sequencing to map the extent of deletion.
The dSmad2
F4 deletion removed a portion of the 59 UTR (break
point at nucleotide 457 of sequence AF101386) and the entire
coding region. The 39 breakpoint was found to be 275 bp
downstream of the dSmad2 transcript and the deletion does not
disrupt the neighboring gene. Several segments of the original P
element were left behind (see Figure 5A). Hemizygous dSmad2
F4
males died as larvae or pupae. The dSmad2
F4 allele was fully
rescued to viability and fertility by one copy of a small duplication
covering dSmad2 (either Dp(1;3)DC185 or Dp(1;3)DC186). An
independent excision allele was generated in parallel from a yellow-
marked P-element insertion (Flybase allele smox
GG01120), using a
slightly different strategy (details available upon request to LAR).
The dSmad2
C15 allele from this screen was found to be an internal
deletion of the transposable element. Like dSmad2
F4, hemizygous
dSmad2
C15 males died as larvae or pupae and were fully rescued by
duplications overlapping dSmad2. We chose the F4 allele for our
mutant analysis because it is an unambiguous protein null.
Supporting Information
Figure S1 Efficient knockdown of sax and tkv in S2
cells. (A) Cells were transfected with a Sax over-expression (O/E)
construct with or without sax RNAi treatment. Western blotting
for Sax showed that the RNAi treatment rendered Sax
undetectable. (B) A similar test for Tkv showed approximately
98% reduction of overexpressed Tkv-FLAG upon RNAi as
detected by FLAG Western blot. In both panels, the loading
control is a FLAG cross-reactive band from the same gel lanes.
Note that endogenous Sax and Tkv are not detected under these
conditions.
(TIF)
Figure S2 Relative phosphorylation of dSmad2 and Mad
are unaffected by knockdown of SARA or disruption of
microtubules. (A) Smad phosphorylation upon Daw treatment
in S2 cells without or with dSARA RNAi. As judged by the FLAG
bands (red in merged image, and isolated in bottom slat), the
RNAi samples had less Smad per lane, but the relative P-dSmad2
versus P-Mad ratios were similar between control and dSARA
RNAi samples. (B) Colcemid treatment did not affect the
preferential activation of dSmad2 by Baboon. In this particular
experiment pMad stimulation by Daw was weak, but P-Mad was
not increased in cells pre-treated with colcemid to depolymerize
microtubules. This is in contrast to the increase in P-Mad caused
by knockdown of dSmad2. Together these suggests that dSmad2
delivery to Baboon is not compromised upon microtubule
disruption. In both panels, rDpp was included as a control for
the ability of the cells to produce P-Mad.
(TIF)
Figure S3 P-Mad elevation in dSmad2 mutants requires
baboon, and occurs in tissues that express a dSmad2
reporter. (A) A chart summarizing P-Mad IHC staining results
in a panel of larval tissues. At least six animals were examined for
control and dSmad2 mutants, and three animals were examined for
babo and dSmad2; babo mutants. Some gut sections were lost during
staining; n.d. indicates that the tissue was not photographed for
that genotype. (B) LacZ staining in G0348 heterozygous female
larvae was used as a proxy for dSmad2 expression because the P-
element insertion into the dSmad2 59 UTR contains a LacZ
reporter. Control animals are shown to indicate very low nuclear
background staining. LacZ was readily detected in several
alimentary tissues and in the fat body. Staining was weak in the
salivary gland, which is a tissue where pMad does not increase in
the dSmad2 null mutant. Displayed images are Maximum Intensity
Projections of confocal sections collected at 3 micron intervals, and
were processed in parallel.
(TIF)
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